Tesofensine Side Effects: The Full Profile and What to Monitor
Most pages selling tesofensine do not publish its side effect profile, because the profile is the reason the drug was never approved. That is exactly backwards for the person taking it. This page gives the incidence figures from the Phase IIb data, the two numbers you should be checking at home, and the point at which you stop and call a prescriber.
8 min read · Updated August 27, 2026
Medically reviewed by Dr. Jonathan Snipes, MD and Kim Callender, NP, FNP-BC. Last reviewed August 27, 2026.Quick Answer
The most common tesofensine side effects are dry mouth (40 to 50 percent), constipation (25 to 35 percent), insomnia (20 to 30 percent), and mood changes or irritability (10 to 15 percent), most of which ease after about four weeks. Separately, tesofensine raises blood pressure and heart rate, and that signal is the specific reason Phase III was never completed and the drug has no FDA approval. Monitor two numbers at home: hold the dose and call if resting heart rate exceeds 100 bpm, and call immediately if blood pressure exceeds 140/90. Side effects are strongly dose-dependent, which is why 0.5 mg daily is the standard.
Why this profile matters more than usual
With most medications, the side effect list is a footnote to an approval decision that already weighed it. With tesofensine the side effect list is the story. Phase IIb produced real weight loss, 9.2 percent at 0.5 mg over 24 weeks in the TIPO-1 trial. It also produced a blood pressure and heart rate signal that concerned reviewers enough that the program stopped there. Phase III was never completed and no new drug application was filed.
That history means two things for anyone considering it. The efficacy is not folklore, it came out of a controlled trial. And the reason you cannot get it at a retail pharmacy is a specific, documented safety finding rather than a bureaucratic accident.
Side effects by frequency
Frequencies below reflect the Phase IIb program and clinical use at the standard 0.5 mg dose. The first two rows are categorically different from the rest: they are monitored parameters rather than symptoms you will necessarily feel.
| Effect | Frequency | When | What to do |
|---|---|---|---|
| Heart rate elevation | Phase IIb signal, monitored | Week 1 onward | Check resting pulse before each dose. Above 100 bpm, hold and contact your prescriber |
| Blood pressure increase | Phase IIb signal, monitored | Week 1 onward | Daily check weeks 1 to 4. Above 140/90, contact your prescriber immediately |
| Dry mouth | Common, 40 to 50 percent | Ongoing | Active hydration through the day. Often improves after week 4 |
| Constipation | Common, 25 to 35 percent | Ongoing | Increase fiber and water. Bulk-forming supplement if persistent |
| Insomnia or disturbed sleep | Common, 20 to 30 percent | First 2 to 4 weeks | Dose in the morning, no caffeine after noon. Usually resolves |
| Mood changes, irritability | 10 to 15 percent at 0.5 mg, higher at 1 mg | Dose-related | Contact your prescriber. Dose reduction or discontinuation is the correct response |
The pattern worth extracting from that table: the symptoms you feel mostly improve, and the parameter you cannot feel mostly does not. People stop tesofensine because of dry mouth and insomnia. The reason to screen carefully before starting is the blood pressure row.
The two numbers to monitor
Because the cardiovascular effect is silent, self-monitoring is not optional on this drug. A home blood pressure cuff costs less than one month of the medication.
- Resting heart rate, before each dose. Above 100 bpm: hold the dose and contact your prescriber the same day. A dose reduction typically resolves it.
- Blood pressure, daily through week four. Above 140/90: contact your prescriber immediately. Uncontrolled hypertension is a contraindication, not a manageable side effect.
Neither threshold means something has gone badly wrong. Both mean the dose is higher than your physiology wants, and the response is to adjust it rather than to push through.
Side effects are dose-dependent, and the math favors 0.5 mg
The Phase IIb dose-response is the most practically useful data in the whole tesofensine literature, because it shows how poor the trade becomes above the standard dose.
| Daily dose | Weight loss at 24 weeks | Side effect burden |
|---|---|---|
| 0.25 mg | 4.5 percent | Lowest |
| 0.5 mg (standard) | 9.2 percent | Moderate, mostly manageable |
| 1.0 mg | 10.6 percent | Markedly higher cardiovascular and psychiatric effects |
Doubling from 0.5 mg to 1.0 mg buys about one further percentage point of weight loss and costs a disproportionate increase in side effects. That is why 0.5 mg once daily in the morning is the standard protocol rather than a starting point to climb from.
Who should not take it at all
These are exclusions rather than cautions, and they are the reason this drug belongs behind a clinical intake instead of in a shopping cart.
- Uncontrolled hypertension. The drug raises blood pressure. Starting from an already elevated baseline compounds the exact risk that halted development.
- Established cardiovascular disease or a history of stroke. Same reasoning, higher stakes.
- Anxiety disorders. Raising noradrenergic tone reliably worsens anxiety in people who already have it.
- Concurrent MAOI use. A serious interaction, not a monitoring item.
This is also the practical argument against buying tesofensine from a marketplace listing or a research-chemical vendor. Not because those products are necessarily different chemically, but because none of them asks any of these questions before shipping. See where tesofensine is actually sold for what those sources are.
How screening works here
Tesofensine at RxPepsDirect is a 500 mcg oral capsule taken once daily in the morning, compounded by Optimal Balance Pharmacy at $2.25 per capsule, dispensed 30 per fill. The intake asks specifically about blood pressure, cardiovascular history, stroke, anxiety, and MAOI use, and a prescriber reviews those answers before anything is written.
It is not the right first choice for most people seeking weight loss. A GLP-1 has better evidence, better tolerability, and no cardiovascular signal. Tesofensine is worth discussing when GLP-1s are contraindicated or poorly tolerated, and it is a conversation with a prescriber rather than a product decision.
Bottom line
Expect dry mouth, constipation and early insomnia as the common experience, most of it easing by about week four. Treat the blood pressure and heart rate signal as the real risk, because it is silent, it is why the drug was never approved, and it is the one thing you can catch at home with a cuff. Stay at 0.5 mg, where the efficacy-to-side-effect trade is best.
For the full protocol, monitoring schedule and trial citations, read the tesofensine protocol guide. For what it actually is, read whether tesofensine is a peptide. For the product itself, see the tesofensine product page.
Common questions about tesofensine side effects
- What are the side effects of tesofensine?
- The most common are dry mouth (40 to 50 percent of patients), constipation (25 to 35 percent), and insomnia or disturbed sleep (20 to 30 percent). Mood changes and irritability affect 10 to 15 percent and become more common above 0.5 mg. Separately from those, tesofensine raises blood pressure and heart rate, which is not a nuisance side effect but the specific finding that ended its development. Most of the common effects ease after roughly four weeks as the monoamine system adapts. The cardiovascular effect does not reliably fade and needs monitoring throughout.
- Is tesofensine bad for your heart?
- It measurably increases blood pressure and heart rate, and that signal is why the Phase IIb program did not advance to Phase III. Whether that is dangerous depends entirely on the individual. In someone with normal blood pressure who is screened first and monitored, the increase is usually modest and dose-responsive, meaning it improves when the dose is lowered. In someone with existing cardiovascular disease, uncontrolled hypertension, or a history of stroke, it is a genuine hazard, and those are absolute contraindications rather than cautions. Nobody should take this drug without a baseline blood pressure reading.
- What should I monitor while taking tesofensine?
- Two numbers. Resting heart rate before each dose: if it is above 100 bpm, hold the dose and contact your prescriber the same day. Blood pressure daily for the first four weeks: if it exceeds 140/90, contact your prescriber immediately. Both usually respond to a dose reduction rather than requiring you to stop. A home cuff costs less than a month of the medication and is not optional equipment for this drug.
- How long do tesofensine side effects last?
- The common ones follow a predictable curve. Insomnia is usually a first two to four week problem and resolves as the monoamine system adapts, especially if the dose is taken in the morning and caffeine is cut after noon. Dry mouth often improves after week four as dopaminergic adaptation occurs, though for some it persists the whole course. Constipation tends to be ongoing rather than self-limiting and needs to be managed with fiber and fluid. The cardiovascular effect is present from week one onward and should be assumed to persist for as long as you are taking it.
- Who should not take tesofensine?
- Anyone with uncontrolled hypertension, established cardiovascular disease, or a history of stroke. Anyone with an anxiety disorder, since a triple monoamine reuptake inhibitor raises noradrenergic tone and can worsen it substantially. Anyone taking an MAOI, which is a serious interaction rather than a caution. These are screened at intake, and a prescriber who does not ask about them before writing for this drug is not screening properly.
- Does tesofensine cause anxiety or mood changes?
- Mood changes and irritability affect roughly 10 to 15 percent at the standard 0.5 mg dose and become notably more common at 1 mg. This is expected pharmacology rather than an idiosyncratic reaction: the drug raises dopamine, noradrenaline and serotonin tone simultaneously, and in a subset of people that presents as agitation rather than as focus. The correct response is dose reduction or discontinuation, not pushing through. If mood changes are significant, contact your prescriber rather than self-adjusting.
- Are tesofensine side effects dose-dependent?
- Almost entirely, which is the single most useful thing to know about managing them. The Phase IIb data showed 4.5 percent weight loss at 0.25 mg, 9.2 percent at 0.5 mg, and 10.6 percent at 1.0 mg over 24 weeks. The jump from 0.5 mg to 1.0 mg roughly doubles the dose for about one additional percentage point of weight loss, while measurably increasing cardiovascular and psychiatric effects. That is why 0.5 mg once daily is the standard and why chasing 1 mg is a poor trade.
- Why was tesofensine never FDA approved?
- Because of the side effects on this page. Phase IIb produced genuine weight loss, 9.2 percent at 0.5 mg over 24 weeks, which is competitive with several approved drugs. It also produced a cardiovascular signal in blood pressure and heart rate that concerned reviewers enough that Phase III was never completed and no NDA was filed. Tesofensine has no FDA approval. It is prescribed and compounded under the 503A pathway, which is a different legal route rather than a way around approval. See how 503A pharmacies work.
Continue reading